Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial
Yan Zhao(Peking University), Jianzhong Zhang(Peking University), Chao Ji(Zhongshan Hospital of Xiamen University), Bin Yang(Southern Medical University), Qingchun Diao(Beijing University of Chinese Medicine), Xiaohua Tao(Zhejiang Provincial People's Hospital), Tao Cai(Third Xiangya Hospital), Rong Xiao(Tongji University), Qianjin Lu(Central South University), Fuqiu Li(Second Affiliated Hospital of Jilin University), Liming Wu(Hangzhou First People's Hospital), Xiao‐Yong Man(Second Affiliated Hospital of Zhejiang University), Lihua Wang(Jinan Central Hospital), Linfeng Li(Beijing Tongren Hospital), Yumei Li(Qingdao University), Jinyan Wang(Ningbo No. 2 Hospital), Xiaohong Zhu(Shanxi Medical University), Yanyan Feng(Shanghai Jiao Tong University), Litao Zhang(Tianjin University of Traditional Chinese Medicine), Hong Ren(The First People’s Hospital of Lianyungang), Jianyun Lu(Central South University), Jingyi Li(Sichuan University), Huiming Zeng(Hainan Medical University), Qing Sun(Qilu Hospital of Shandong University)
Cited by 30
Related Papers
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus
|Nature Genetics|2009|951
Demethylation of <i>CD40LG</i> on the Inactive X in T Cells from Women with Lupus
|The Journal of Immunology|2007|466
Induced Regulatory T Cells: Their Development, Stability, and Applications
|Trends in Immunology|2016|451
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review
|Clinical Reviews in Allergy & Immunology|2013|372